Persistent Fetal SVT in a COVID-19 Positive Pregnancy


Mid America


Menorah Medical Center

Document Type

Case Report

Publication Date



sars-cov-2, coronavirus infections, COVID-19, upraventricular tachycardia


Cardiovascular Diseases | Female Urogenital Diseases and Pregnancy Complications | Obstetrics and Gynecology | Virus Diseases


Background: Rapid introduction and spread of SARS-CoV-2 have posed unique challenges in understanding the disease, role in vertical transmission, and in developing management. We present a case of a patient with COVID-19 infection and fetus with new-onset fetal SVT.

Case: A 26-year-old gravida 4 para 2012 with third trimester COVID-19 infection was diagnosed with new onset fetal SVT. Successful cardioversion was achieved with flecainide. The patient was followed outpatient until induction of labor at 39 and 3/7 weeks of gestational age resulting in an uncomplicated vaginal delivery. Postpartum course was uncomplicated.

Conclusion: Fetal SVT is a potential complication of maternal COVID-19 infection. The use of transplacental therapy with flecainide is an appropriate alternative to digoxin in these cases.

Publisher or Conference

Case Reports in Obstetrics and Gynecology